Vascular Closure Device Market, by Product Type (Passive Vascular Closure Devices, Active Vascular Closure Devices, and External Hemostatic Devices), By Access (Femoral, and Radial), By Hole Size (Small Hole, and Large Hole) By End User (Hospital, Ambulatory Surgical Centers, and Others) and by Region - Global Trends, and Forecast to 2025

Vascular Closure Devices Market Insights

Vascular closure devices (VCDs) are medical devices used to achieve vascular hemostasis after the puncture of femoral artery during diagnostic angiography procedures or interventional procedures. VCDs are developed as an alternative of mechanical compression. Although mechanical compression is effective method for treatment of hemostasis, it take a longer time period to effectively achieve hemostasis than vascular closure devices. VCDs has been available in the U.S. since 1995, when St. Jude Medical, Inc. received the approval for VasoSeal device. Since then, number of leading medical devices such as Abbott Laboratories, Medtronic Plc, and Terumo Corporation companies have entered in the market.

Frequent approval of novel vascular closure devices by regulatory bodies in key regions is expected to drive market growth

In recent past, number of vascular closure devices have received approval from different regulatory bodies in key region such as North America and Europe, which is expected to boost growth of the market in near future. For instance in 2016, Vivasure Medical Ltd. received CE Mark for bioabsorbable percutaneous closure device for large-bore transcatheter procedures. In 2016 Essential Medical Inc. received CE Mark for X-Seal 6F vascular closure device. X-Seal 6F has also received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin the US clinical trial. X-seal 6F device is the advanced vascular closure device that has novel deployment control features and provides consistent closure performance. In 2016, Essential Medical, Inc., received CE Mark approval for product MANTA. MANTA is a large hole vascular closure device that can be used after catheterization procedures such as transcatheter aortic valve replacement, endovascular treatment of abdominal aortic aneurysms, ventricular assist, and others. In 2013, Cardiva Medical, Inc. received FDA Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS). VASCADE VCS is an extravascular bio absorbable closure device. Furthermore launches of novel vascular devices is also expected to drive its market growth. For instance in 2017 Vasorum Ltd. Launched Celt ACD Second Generation Vascular Closure Device in the U.S. and in 2014, AccessClosure Inc. launched Mynx Ace vascular closure device.

The global vascular closure devices market was valued at US$ 848.2 million in 2016 and is expected to witness a CAGR of 6.1% over the forecast period (2017 – 2025).

Figure 1. Global Vascular Closure Devices Market Share, By Region, 2016 & 2025

vascular closure devices market

Source: Coherent Market Insights Analysis (2017)

Increasing demand for angiography due to increasing prevalence of cardiovascular diseases is expected to derive growth for vascular closure devices market

Vascular closure device are primarily used for vascular hemostasis after puncture of the femoral artery during angiography. Angiography is an imaging technique used to visualize interior of blood vessels including artery. The technique has been increasingly used for finding out if the arteries are blocked, closed or narrowed. According to research published by World Health Organization (WHO) in 2017, about 17.7 million people died from cardiovascular diseases in 2015, which is about 31% of all global deaths. Among these death around 7.4 million death were due to coronary heart disease and 6.7 million were due to stroke. As the prevalence of the cardiovascular disease is increasing, the demand for angiography, a diagnosis technique, is expected to increase which in turn will lead to growth in global vascular closure devices market.

This market has witnessed few recalls, which has proved to be major restraining factor for market growth. For instance, in 2017 Abbott Vascular recall 66 lots of the StarClose SE Vascular system due to difficulty in deploying the clip.

Furthermore, vascular closure devices manufacturing companies have been successful in raising funds from investors to expand business. In 2016, Vivasure Medical, a company developing a novel bioabsorbable technology for percutaneous vessel closure, has received Series C funding of US$ 18.3 Mn. This funding round was led by Life Sciences Partners (LSP) of The Netherlands, investing from its LSP Health Economics Fund, and co-led by Evonik Venture Capital.

Key players operating in the global vascular closure devices market include Abbott Laboratories, Medtronic Plc, Transluminal Technologies LLC, Cardinal Health, Inc., Cardiva Medical, Inc., Terumo Corporation, Essential Medical, Inc., Vascular Closure Systems, Inc., Vivasure Medical Ltd., Vasorum Ltd., and Morris Innovative Inc.

Vascular closure devices are medical devices used in sealing puncture of the femoral artery in patients who have undergone diagnostic angiography procedures or interventional procedures. Vascular closure devices are alternative to manual compression method, manually compression takes longer time, depending on the size of the plastic sheath placed in the artery. Vascular closure devices provide immediate sealing of the femoral artery access site, which is not the case with mechanical or manual compression.

Market Dynamics

Increasing demand for diagnostic angiography procedures due to increasing prevalence of Coronary heart disease (CHD) is expected to increase demand for vascular closure device in near future. For instance according to the research published in Centers for Disease Control and Prevention (CDC) in 2017, Coronary heart disease (CHD) is one common type of heart disease, which causes about 370,000 deaths in U.S. annually. Furthermore the launch of innovative vascular closure devices in market is also expected create lucrative environment for market growth. For instance in 2014, AccessClosure Inc. launched Mynx Ace vascular closure device at annual scientific session of the American College of Cardiology in Washington, DC. Furthermore, in 2017, Vasorum Ltd. launched Celt ACD second generation vascular closure device in the U.S. market.

Key features of the study:

  • This report provides in-depth analysis of vascular closure devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global vascular closure devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Medtronic Plc., Transluminal Technologies LLC, Cardinal Health, Inc., Cardiva Medical, Inc., Terumo Corporation, Essential Medical, Inc., Vascular Closure Systems, Inc., Vivasure Medical Ltd., Vasorum Ltd. , and Morris Innovative Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global vascular closure devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the vascular closure devices market

Detailed Segmentation:

  • Global Vascular Closure Devices Market, By Product Type:
    • Passive Vascular Closure Devices
      • Plug-Based Devices
      • Sealant or Gel-Based Devices
      • Compression Assist Devices
    • Active Vascular Closure Devices
      • Clip-Based Devices
      • Suture-Based Devices
    • External Hemostatic Devices
  • Global Vascular Closure Devices Market, By Access:
    • Femoral
    • Radial
  • Global Vascular Closure Devices Market, By Hole Size:
    • Small Hole
    • Large Hole
  • Global Vascular Closure Devices Market, By End User:
    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • Global Vascular Closure Devices Market, By Geography:
    • North America
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Passive Vascular Closure Devices
          • Plug-Based Devices
          • Sealant or Gel-Based Devices
          • Compression Assist Devices
        • Active Vascular Closure Devices
          • Clip-Based Devices
          • Suture-Based Devices
        • External Hemostatic Devices
      • By Access:
        • Femoral
        • Radial
      • By Hole Size
        • Small Hole
        • Large Hole
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Medtronic Plc
    • Transluminal Technologies LLC
    • Cardinal Health, Inc.
    • Cardiva Medical, Inc.
    • Terumo Corporation
    • Essential Medical, Inc.
    • Vascular Closure Systems, Inc.
    • Vivasure Medical Ltd.
    • Vasorum Ltd.
    • Morris Innovative Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Access
      • Market Snippet, By Hole Size
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Trends
    • Unmet Needs
    • Regulatory Scenario
    • Recent Product Launch
    • Technological Advancement
    • PEST Analysis
    • Porter’s Analysis
  4. Global Vascular Closure Devices Market, By Product Type, 2017 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Passive Vascular Closure Devices
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
      • Segment Trends
        • Plug-Based Devices
        • Sealant or Gel-Based Devices
        • Compression Assist Devices
    • Active Vascular Closure Devices
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
      • Segment Trends
        • Clip-Based Devices
        • Suture-Based Devices
    • External Hemostatic Devices
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
  5. Global Vascular Closure Devices Market, By Access, 2017 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Femoral
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
    • Radial
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
  6. Global Vascular Closure Devices Market, By Hole Size, 2017 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Small Hole
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
    • Large Hole
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
  7. Global Vascular Closure Devices Market, By End User, 2017 – 2025 (US$ Mn)
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Mn)
  8. Global Vascular Closure Devices Market, By Regions, 2017 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 – 2025
    • North America
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Access, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Hole Size, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Transluminal Technologies LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cardinal Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cardiva Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Essential Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Vascular Closure Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Vivasure Medical Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Vasorum Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Morris Innovative Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 34 market data tables and 28 figures on "Vascular Closure Devices Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.